Aue, G., Sun, C., Liu, D., Park, J., Pittaluga, S., Tian, X., . . . Wiestner, A. (2018). Activation of Th1 Immunity Within the Tumor Microenvironment is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia($). J Immunol.
Styl cytowania ChicagoAue, Georg, et al. "Activation of Th1 Immunity Within the Tumor Microenvironment Is Associated With Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia($)." J Immunol 2018.
Styl cytowania MLAAue, Georg, et al. "Activation of Th1 Immunity Within the Tumor Microenvironment Is Associated With Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia($)." J Immunol 2018.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..